Review




Structured Review

GenScript corporation wt and mutant mouse ctcf cdna
<t>CTCF</t> complementation system (A) Scheme of the CTCF doxycycline-inducible degron system. (B) Experimental strategy for the expression of WT and mutant transgenic CTCF. (C) Flow cytometry showing the level of GFP (endogenous CTCF) and mRuby (transgenic WT CTCF). (D) Left, scheme showing the locations of the different types of CTCF mutations within a ZF. Amino acids making contacts with the DNA are shown in shades of pink, residues that coordinate the zinc ion in red, boundary residues in purple, and residues that contact the sugar phosphate backbone of DNA in blue. Right, representation of CTCF showing the locations of each mutation under investigation. (E) Bar graph showing the expression levels (mean fluorescence intensity) of endogenous CTCF (GFP) and transgenic WT or mutant CTCF (mRuby2) after ID treatment. The error bars represent the standard deviation between the two replicates. (F) Western blot of endogenous CTCF (CTCF antibody) and transgenic CTCF (FLAG antibody) in untreated (WT-U), IAA, ID conditions. See also <xref ref-type=Figures S1–S5 . " width="250" height="auto" />
Wt And Mutant Mouse Ctcf Cdna, supplied by GenScript corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/wt and mutant mouse ctcf cdna/product/GenScript corporation
Average 90 stars, based on 1 article reviews
wt and mutant mouse ctcf cdna - by Bioz Stars, 2026-03
90/100 stars

Images

1) Product Images from "Binding domain mutations provide insight into CTCF’s relationship with chromatin and its contribution to gene regulation"

Article Title: Binding domain mutations provide insight into CTCF’s relationship with chromatin and its contribution to gene regulation

Journal: Cell Genomics

doi: 10.1016/j.xgen.2025.100813

CTCF complementation system (A) Scheme of the CTCF doxycycline-inducible degron system. (B) Experimental strategy for the expression of WT and mutant transgenic CTCF. (C) Flow cytometry showing the level of GFP (endogenous CTCF) and mRuby (transgenic WT CTCF). (D) Left, scheme showing the locations of the different types of CTCF mutations within a ZF. Amino acids making contacts with the DNA are shown in shades of pink, residues that coordinate the zinc ion in red, boundary residues in purple, and residues that contact the sugar phosphate backbone of DNA in blue. Right, representation of CTCF showing the locations of each mutation under investigation. (E) Bar graph showing the expression levels (mean fluorescence intensity) of endogenous CTCF (GFP) and transgenic WT or mutant CTCF (mRuby2) after ID treatment. The error bars represent the standard deviation between the two replicates. (F) Western blot of endogenous CTCF (CTCF antibody) and transgenic CTCF (FLAG antibody) in untreated (WT-U), IAA, ID conditions. See also <xref ref-type=Figures S1–S5 . " title="CTCF complementation system (A) Scheme of the CTCF doxycycline-inducible ..." property="contentUrl" width="100%" height="100%"/>
Figure Legend Snippet: CTCF complementation system (A) Scheme of the CTCF doxycycline-inducible degron system. (B) Experimental strategy for the expression of WT and mutant transgenic CTCF. (C) Flow cytometry showing the level of GFP (endogenous CTCF) and mRuby (transgenic WT CTCF). (D) Left, scheme showing the locations of the different types of CTCF mutations within a ZF. Amino acids making contacts with the DNA are shown in shades of pink, residues that coordinate the zinc ion in red, boundary residues in purple, and residues that contact the sugar phosphate backbone of DNA in blue. Right, representation of CTCF showing the locations of each mutation under investigation. (E) Bar graph showing the expression levels (mean fluorescence intensity) of endogenous CTCF (GFP) and transgenic WT or mutant CTCF (mRuby2) after ID treatment. The error bars represent the standard deviation between the two replicates. (F) Western blot of endogenous CTCF (CTCF antibody) and transgenic CTCF (FLAG antibody) in untreated (WT-U), IAA, ID conditions. See also Figures S1–S5 .

Techniques Used: Expressing, Mutagenesis, Transgenic Assay, Flow Cytometry, Fluorescence, Standard Deviation, Western Blot

CTCF mutations have unique chromatin binding profiles (A) Scheme showing the locations of the CTCF mutations within the ZF. The consensus CTCF motif highlights the triplet to which each mutant ZF binds (top). The most common motif for the de novo binding sites is shown below. Each bar graph shows the percentage of WT-only, common, and mutant-only CTCF binding sites. The heatmaps show the profile of CTCF and ATAC-seq signal at those sites. The UN condition corresponds to the FLAG control. (B) Profiles of ATAC-seq in WT and mutants. Wilcoxon p values were coded as follow: NS, not significant, ∗5 × 10 −2 –5 × 10 −3 , ∗∗5 × 10 −3 –5 × 10 −4 , ∗∗∗5 × 10 −4 –5 × 10 −5 , ∗∗∗∗<5 × 10 −5 . Data were generated on 2 replicates. See also <xref ref-type=Figures S6–S9 . " title="CTCF mutations have unique chromatin binding profiles (A) Scheme ..." property="contentUrl" width="100%" height="100%"/>
Figure Legend Snippet: CTCF mutations have unique chromatin binding profiles (A) Scheme showing the locations of the CTCF mutations within the ZF. The consensus CTCF motif highlights the triplet to which each mutant ZF binds (top). The most common motif for the de novo binding sites is shown below. Each bar graph shows the percentage of WT-only, common, and mutant-only CTCF binding sites. The heatmaps show the profile of CTCF and ATAC-seq signal at those sites. The UN condition corresponds to the FLAG control. (B) Profiles of ATAC-seq in WT and mutants. Wilcoxon p values were coded as follow: NS, not significant, ∗5 × 10 −2 –5 × 10 −3 , ∗∗5 × 10 −3 –5 × 10 −4 , ∗∗∗5 × 10 −4 –5 × 10 −5 , ∗∗∗∗<5 × 10 −5 . Data were generated on 2 replicates. See also Figures S6–S9 .

Techniques Used: Binding Assay, Mutagenesis, Control, Generated

Each mutation uniquely impacts CTCF’s chromatin bound fraction, residence time, and interaction with DNA (A) Plots of FRAP dynamics for WT and mutant CTCF. The bold lines show the fitted model of the average recovery, and the outlines give the 95% confidence intervals (95% CIs). (B) Violin plots of specific bound fractions. (C) Violin plots of specific residence times (min). p values were determined by bootstrapping ( n = 2,500). (D) Heatmaps show the proportion of CTCF-cohesin versus CTCF-only binding sites. UN corresponds to the FLAG control in untreated cells. (E) Correlation between residence time and the percentage of CTCF-cohesin overlap. (F) Correlation between the FRAP-specific bound fraction relative to WT and the fraction of common CTCF sites relative to all potential binding sites. (G) Correlation between the FRAP-specific bound fraction relative to WT and the effect of CTCF binding on ATAC-seq signal at CTCF-SMC3 sites ( <xref ref-type=Figure 2 B). For (E)–(G), data were generated in 2 replicates, the p values were calculated using linear regression, and the shaded area corresponds to the 95% CI. See also Figures S10–S14 . " title="... Plots of FRAP dynamics for WT and mutant CTCF. The bold lines show the fitted model of ..." property="contentUrl" width="100%" height="100%"/>
Figure Legend Snippet: Each mutation uniquely impacts CTCF’s chromatin bound fraction, residence time, and interaction with DNA (A) Plots of FRAP dynamics for WT and mutant CTCF. The bold lines show the fitted model of the average recovery, and the outlines give the 95% confidence intervals (95% CIs). (B) Violin plots of specific bound fractions. (C) Violin plots of specific residence times (min). p values were determined by bootstrapping ( n = 2,500). (D) Heatmaps show the proportion of CTCF-cohesin versus CTCF-only binding sites. UN corresponds to the FLAG control in untreated cells. (E) Correlation between residence time and the percentage of CTCF-cohesin overlap. (F) Correlation between the FRAP-specific bound fraction relative to WT and the fraction of common CTCF sites relative to all potential binding sites. (G) Correlation between the FRAP-specific bound fraction relative to WT and the effect of CTCF binding on ATAC-seq signal at CTCF-SMC3 sites ( Figure 2 B). For (E)–(G), data were generated in 2 replicates, the p values were calculated using linear regression, and the shaded area corresponds to the 95% CI. See also Figures S10–S14 .

Techniques Used: Mutagenesis, Binding Assay, Control, Generated

Effect of CTCF binding and accessibility on SMC3 overlap (A) Bar graph showing the independent effect of CTCF (top) and ATAC-seq (bottom) signal on SMC3 enrichment in WT. The error bars correspond to the 95% CIs. The p values were calculated using a multivariate logistic model. (B) Percentage of SMC3 overlap in WT and CTCF mutants, stratified by ATAC-seq and CTCF signals. (C) SMC3 profiles in WT and mutant CTCF. p values were calculated using Wilcoxon tests. See also <xref ref-type=Figures S15 , , and Table S1 . " title="Effect of CTCF binding and accessibility on SMC3 overlap (A) Bar ..." property="contentUrl" width="100%" height="100%"/>
Figure Legend Snippet: Effect of CTCF binding and accessibility on SMC3 overlap (A) Bar graph showing the independent effect of CTCF (top) and ATAC-seq (bottom) signal on SMC3 enrichment in WT. The error bars correspond to the 95% CIs. The p values were calculated using a multivariate logistic model. (B) Percentage of SMC3 overlap in WT and CTCF mutants, stratified by ATAC-seq and CTCF signals. (C) SMC3 profiles in WT and mutant CTCF. p values were calculated using Wilcoxon tests. See also Figures S15 , , and Table S1 .

Techniques Used: Binding Assay, Mutagenesis

CTCF mutations alter gene expression, cellular reprogramming, and TF binding (A) Heatmap showing supervised clustering of the cell lines based on the expression levels of DEGs identified across the comparisons to WT. (B) Gene set enrichment analysis of DEGs in IAA condition and in H455R. The volcano plots below highlight the DEGs belonging to these enriched pathways. (C) Radar plots showing the averaged expression of developmental germ layer genes in WT and mutant mESCs cultured in LIF and no LIF conditions. (D) Heatmap showing predicted differentially bound TFs in WT, mutants and IAA. CTCF is highlighted with an asterisk (∗). (E) Volcano plots highlighting the differentially expressed target genes of CTCF and MBD2 in IAA and CTCF mutants. The metrics for enrichment of the target genes among the DEGs are reported on top on the volcanos (ORs and logistic p values). (F) Examples of altered CTCF binding and footprinting at the Rerg promoter (left) and altered MYC footprinting at the Brdt promoter (right). All data in this figure were generated on 2 replicates. See also <xref ref-type=Figures S17–S20 and Table S2. Differentially expressed genes (DEGs) identified using DE-seq. DEGs were defined as adjusted genes with p-value<0.05 and absolute log2 fold change > log2(1.5) compared to WT , Table S3. CTCF mutations altered cell differentiation , Table S4. CTCF mutations altered TF binding . " title="CTCF mutations alter gene expression, cellular reprogramming, and TF ..." property="contentUrl" width="100%" height="100%"/>
Figure Legend Snippet: CTCF mutations alter gene expression, cellular reprogramming, and TF binding (A) Heatmap showing supervised clustering of the cell lines based on the expression levels of DEGs identified across the comparisons to WT. (B) Gene set enrichment analysis of DEGs in IAA condition and in H455R. The volcano plots below highlight the DEGs belonging to these enriched pathways. (C) Radar plots showing the averaged expression of developmental germ layer genes in WT and mutant mESCs cultured in LIF and no LIF conditions. (D) Heatmap showing predicted differentially bound TFs in WT, mutants and IAA. CTCF is highlighted with an asterisk (∗). (E) Volcano plots highlighting the differentially expressed target genes of CTCF and MBD2 in IAA and CTCF mutants. The metrics for enrichment of the target genes among the DEGs are reported on top on the volcanos (ORs and logistic p values). (F) Examples of altered CTCF binding and footprinting at the Rerg promoter (left) and altered MYC footprinting at the Brdt promoter (right). All data in this figure were generated on 2 replicates. See also Figures S17–S20 and Table S2. Differentially expressed genes (DEGs) identified using DE-seq. DEGs were defined as adjusted genes with p-value<0.05 and absolute log2 fold change > log2(1.5) compared to WT , Table S3. CTCF mutations altered cell differentiation , Table S4. CTCF mutations altered TF binding .

Techniques Used: Gene Expression, Binding Assay, Expressing, Mutagenesis, Cell Culture, Footprinting, Generated, Cell Differentiation

CTCF mutations alter chromatin interactivity (A) The top panels show the aggregated differential TAD analysis between mutants and WT. In the first panel, (a) indicates the intra-TAD interaction, (b) and (c) the inter-TAD interactions. The lower panels show the aggregated differential peak analysis. The data were generated by Hi-C on 2 replicates. (B) Correlation between the interaction counts and the FRAP residence times. (C) Correlation between the insulation score at CTCF peaks and the FRAP residence times. (D) Correlation between the loop extrusion length and the FRAP bound fractions. (E) Example of differential interactions between mutants and WT (right). The left matrix shows interactions in WT within a 10 Mb region (40 kb resolution) with the insulation score on the side. (F) Profiles show the averaged insulation score at WT-only, common, and mutant-only binding sites. (G) Profiles show the insulation score at CTCF binding sites stratified by CTCF signals. The bar graph shows the independent effect of CTCF signal on insulation score. (H) Profiles show the insulation score at CTCF binding sites stratified by ATAC signals. The bar graph shows the independent effect of ATAC signal on insulation score. For (F)–(H), p values reported in the profiles were calculated using Kruskal-Wallis tests. The fitted estimates for the bar graphs in (G) and (H) were obtained using a mixed multivariate model. The error bars correspond to the 95% CI. See also <xref ref-type=Figures S21–S24 . " title="CTCF mutations alter chromatin interactivity (A) The top panels ..." property="contentUrl" width="100%" height="100%"/>
Figure Legend Snippet: CTCF mutations alter chromatin interactivity (A) The top panels show the aggregated differential TAD analysis between mutants and WT. In the first panel, (a) indicates the intra-TAD interaction, (b) and (c) the inter-TAD interactions. The lower panels show the aggregated differential peak analysis. The data were generated by Hi-C on 2 replicates. (B) Correlation between the interaction counts and the FRAP residence times. (C) Correlation between the insulation score at CTCF peaks and the FRAP residence times. (D) Correlation between the loop extrusion length and the FRAP bound fractions. (E) Example of differential interactions between mutants and WT (right). The left matrix shows interactions in WT within a 10 Mb region (40 kb resolution) with the insulation score on the side. (F) Profiles show the averaged insulation score at WT-only, common, and mutant-only binding sites. (G) Profiles show the insulation score at CTCF binding sites stratified by CTCF signals. The bar graph shows the independent effect of CTCF signal on insulation score. (H) Profiles show the insulation score at CTCF binding sites stratified by ATAC signals. The bar graph shows the independent effect of ATAC signal on insulation score. For (F)–(H), p values reported in the profiles were calculated using Kruskal-Wallis tests. The fitted estimates for the bar graphs in (G) and (H) were obtained using a mixed multivariate model. The error bars correspond to the 95% CI. See also Figures S21–S24 .

Techniques Used: Generated, Hi-C, Insulation, Mutagenesis, Binding Assay

Changes in gene expression are linked to changes in chromatin interactivity but to a lesser extent than changes in TF binding at gene promoters (A) Bar graphs showing the enrichment of over-expressed (top) or under-expressed (bottom) genes in gained (top) or lost (bottom) loops in IAA and mutants compared to WT. ORs and p values were calculated using logistic models. (B) Example of 2 loci (blue and red rectangles) with a direct effect of gain in CTCF binding and chromatin interactivity. The interaction matrices (left) show gain of both intra- and inter-TAD interactions in some mutants compared to WT. The left panels show the zoom-in tracks of these loci. Only significant differential chromatin loops are shown. Overexpressed genes are highlighted in red. (C) Bar graph showing the percentage of DEGs resulting from direct or indirect effect of CTCF binding distinguishing loop dependent and independent effect.
Figure Legend Snippet: Changes in gene expression are linked to changes in chromatin interactivity but to a lesser extent than changes in TF binding at gene promoters (A) Bar graphs showing the enrichment of over-expressed (top) or under-expressed (bottom) genes in gained (top) or lost (bottom) loops in IAA and mutants compared to WT. ORs and p values were calculated using logistic models. (B) Example of 2 loci (blue and red rectangles) with a direct effect of gain in CTCF binding and chromatin interactivity. The interaction matrices (left) show gain of both intra- and inter-TAD interactions in some mutants compared to WT. The left panels show the zoom-in tracks of these loci. Only significant differential chromatin loops are shown. Overexpressed genes are highlighted in red. (C) Bar graph showing the percentage of DEGs resulting from direct or indirect effect of CTCF binding distinguishing loop dependent and independent effect.

Techniques Used: Gene Expression, Binding Assay



Similar Products

90
GenScript corporation wt and mutant mouse ctcf cdna
<t>CTCF</t> complementation system (A) Scheme of the CTCF doxycycline-inducible degron system. (B) Experimental strategy for the expression of WT and mutant transgenic CTCF. (C) Flow cytometry showing the level of GFP (endogenous CTCF) and mRuby (transgenic WT CTCF). (D) Left, scheme showing the locations of the different types of CTCF mutations within a ZF. Amino acids making contacts with the DNA are shown in shades of pink, residues that coordinate the zinc ion in red, boundary residues in purple, and residues that contact the sugar phosphate backbone of DNA in blue. Right, representation of CTCF showing the locations of each mutation under investigation. (E) Bar graph showing the expression levels (mean fluorescence intensity) of endogenous CTCF (GFP) and transgenic WT or mutant CTCF (mRuby2) after ID treatment. The error bars represent the standard deviation between the two replicates. (F) Western blot of endogenous CTCF (CTCF antibody) and transgenic CTCF (FLAG antibody) in untreated (WT-U), IAA, ID conditions. See also <xref ref-type=Figures S1–S5 . " width="250" height="auto" />
Wt And Mutant Mouse Ctcf Cdna, supplied by GenScript corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/wt and mutant mouse ctcf cdna/product/GenScript corporation
Average 90 stars, based on 1 article reviews
wt and mutant mouse ctcf cdna - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

Image Search Results


CTCF complementation system (A) Scheme of the CTCF doxycycline-inducible degron system. (B) Experimental strategy for the expression of WT and mutant transgenic CTCF. (C) Flow cytometry showing the level of GFP (endogenous CTCF) and mRuby (transgenic WT CTCF). (D) Left, scheme showing the locations of the different types of CTCF mutations within a ZF. Amino acids making contacts with the DNA are shown in shades of pink, residues that coordinate the zinc ion in red, boundary residues in purple, and residues that contact the sugar phosphate backbone of DNA in blue. Right, representation of CTCF showing the locations of each mutation under investigation. (E) Bar graph showing the expression levels (mean fluorescence intensity) of endogenous CTCF (GFP) and transgenic WT or mutant CTCF (mRuby2) after ID treatment. The error bars represent the standard deviation between the two replicates. (F) Western blot of endogenous CTCF (CTCF antibody) and transgenic CTCF (FLAG antibody) in untreated (WT-U), IAA, ID conditions. See also <xref ref-type=Figures S1–S5 . " width="100%" height="100%">

Journal: Cell Genomics

Article Title: Binding domain mutations provide insight into CTCF’s relationship with chromatin and its contribution to gene regulation

doi: 10.1016/j.xgen.2025.100813

Figure Lengend Snippet: CTCF complementation system (A) Scheme of the CTCF doxycycline-inducible degron system. (B) Experimental strategy for the expression of WT and mutant transgenic CTCF. (C) Flow cytometry showing the level of GFP (endogenous CTCF) and mRuby (transgenic WT CTCF). (D) Left, scheme showing the locations of the different types of CTCF mutations within a ZF. Amino acids making contacts with the DNA are shown in shades of pink, residues that coordinate the zinc ion in red, boundary residues in purple, and residues that contact the sugar phosphate backbone of DNA in blue. Right, representation of CTCF showing the locations of each mutation under investigation. (E) Bar graph showing the expression levels (mean fluorescence intensity) of endogenous CTCF (GFP) and transgenic WT or mutant CTCF (mRuby2) after ID treatment. The error bars represent the standard deviation between the two replicates. (F) Western blot of endogenous CTCF (CTCF antibody) and transgenic CTCF (FLAG antibody) in untreated (WT-U), IAA, ID conditions. See also Figures S1–S5 .

Article Snippet: Construction of vector for cloning transgenic, doxycycline-inducible expression of WT and mutant mouse Ctcf cDNA were obtained from GenScript in pUC19 vectors.

Techniques: Expressing, Mutagenesis, Transgenic Assay, Flow Cytometry, Fluorescence, Standard Deviation, Western Blot

CTCF mutations have unique chromatin binding profiles (A) Scheme showing the locations of the CTCF mutations within the ZF. The consensus CTCF motif highlights the triplet to which each mutant ZF binds (top). The most common motif for the de novo binding sites is shown below. Each bar graph shows the percentage of WT-only, common, and mutant-only CTCF binding sites. The heatmaps show the profile of CTCF and ATAC-seq signal at those sites. The UN condition corresponds to the FLAG control. (B) Profiles of ATAC-seq in WT and mutants. Wilcoxon p values were coded as follow: NS, not significant, ∗5 × 10 −2 –5 × 10 −3 , ∗∗5 × 10 −3 –5 × 10 −4 , ∗∗∗5 × 10 −4 –5 × 10 −5 , ∗∗∗∗<5 × 10 −5 . Data were generated on 2 replicates. See also <xref ref-type=Figures S6–S9 . " width="100%" height="100%">

Journal: Cell Genomics

Article Title: Binding domain mutations provide insight into CTCF’s relationship with chromatin and its contribution to gene regulation

doi: 10.1016/j.xgen.2025.100813

Figure Lengend Snippet: CTCF mutations have unique chromatin binding profiles (A) Scheme showing the locations of the CTCF mutations within the ZF. The consensus CTCF motif highlights the triplet to which each mutant ZF binds (top). The most common motif for the de novo binding sites is shown below. Each bar graph shows the percentage of WT-only, common, and mutant-only CTCF binding sites. The heatmaps show the profile of CTCF and ATAC-seq signal at those sites. The UN condition corresponds to the FLAG control. (B) Profiles of ATAC-seq in WT and mutants. Wilcoxon p values were coded as follow: NS, not significant, ∗5 × 10 −2 –5 × 10 −3 , ∗∗5 × 10 −3 –5 × 10 −4 , ∗∗∗5 × 10 −4 –5 × 10 −5 , ∗∗∗∗<5 × 10 −5 . Data were generated on 2 replicates. See also Figures S6–S9 .

Article Snippet: Construction of vector for cloning transgenic, doxycycline-inducible expression of WT and mutant mouse Ctcf cDNA were obtained from GenScript in pUC19 vectors.

Techniques: Binding Assay, Mutagenesis, Control, Generated

Each mutation uniquely impacts CTCF’s chromatin bound fraction, residence time, and interaction with DNA (A) Plots of FRAP dynamics for WT and mutant CTCF. The bold lines show the fitted model of the average recovery, and the outlines give the 95% confidence intervals (95% CIs). (B) Violin plots of specific bound fractions. (C) Violin plots of specific residence times (min). p values were determined by bootstrapping ( n = 2,500). (D) Heatmaps show the proportion of CTCF-cohesin versus CTCF-only binding sites. UN corresponds to the FLAG control in untreated cells. (E) Correlation between residence time and the percentage of CTCF-cohesin overlap. (F) Correlation between the FRAP-specific bound fraction relative to WT and the fraction of common CTCF sites relative to all potential binding sites. (G) Correlation between the FRAP-specific bound fraction relative to WT and the effect of CTCF binding on ATAC-seq signal at CTCF-SMC3 sites ( <xref ref-type=Figure 2 B). For (E)–(G), data were generated in 2 replicates, the p values were calculated using linear regression, and the shaded area corresponds to the 95% CI. See also Figures S10–S14 . " width="100%" height="100%">

Journal: Cell Genomics

Article Title: Binding domain mutations provide insight into CTCF’s relationship with chromatin and its contribution to gene regulation

doi: 10.1016/j.xgen.2025.100813

Figure Lengend Snippet: Each mutation uniquely impacts CTCF’s chromatin bound fraction, residence time, and interaction with DNA (A) Plots of FRAP dynamics for WT and mutant CTCF. The bold lines show the fitted model of the average recovery, and the outlines give the 95% confidence intervals (95% CIs). (B) Violin plots of specific bound fractions. (C) Violin plots of specific residence times (min). p values were determined by bootstrapping ( n = 2,500). (D) Heatmaps show the proportion of CTCF-cohesin versus CTCF-only binding sites. UN corresponds to the FLAG control in untreated cells. (E) Correlation between residence time and the percentage of CTCF-cohesin overlap. (F) Correlation between the FRAP-specific bound fraction relative to WT and the fraction of common CTCF sites relative to all potential binding sites. (G) Correlation between the FRAP-specific bound fraction relative to WT and the effect of CTCF binding on ATAC-seq signal at CTCF-SMC3 sites ( Figure 2 B). For (E)–(G), data were generated in 2 replicates, the p values were calculated using linear regression, and the shaded area corresponds to the 95% CI. See also Figures S10–S14 .

Article Snippet: Construction of vector for cloning transgenic, doxycycline-inducible expression of WT and mutant mouse Ctcf cDNA were obtained from GenScript in pUC19 vectors.

Techniques: Mutagenesis, Binding Assay, Control, Generated

Effect of CTCF binding and accessibility on SMC3 overlap (A) Bar graph showing the independent effect of CTCF (top) and ATAC-seq (bottom) signal on SMC3 enrichment in WT. The error bars correspond to the 95% CIs. The p values were calculated using a multivariate logistic model. (B) Percentage of SMC3 overlap in WT and CTCF mutants, stratified by ATAC-seq and CTCF signals. (C) SMC3 profiles in WT and mutant CTCF. p values were calculated using Wilcoxon tests. See also <xref ref-type=Figures S15 , , and Table S1 . " width="100%" height="100%">

Journal: Cell Genomics

Article Title: Binding domain mutations provide insight into CTCF’s relationship with chromatin and its contribution to gene regulation

doi: 10.1016/j.xgen.2025.100813

Figure Lengend Snippet: Effect of CTCF binding and accessibility on SMC3 overlap (A) Bar graph showing the independent effect of CTCF (top) and ATAC-seq (bottom) signal on SMC3 enrichment in WT. The error bars correspond to the 95% CIs. The p values were calculated using a multivariate logistic model. (B) Percentage of SMC3 overlap in WT and CTCF mutants, stratified by ATAC-seq and CTCF signals. (C) SMC3 profiles in WT and mutant CTCF. p values were calculated using Wilcoxon tests. See also Figures S15 , , and Table S1 .

Article Snippet: Construction of vector for cloning transgenic, doxycycline-inducible expression of WT and mutant mouse Ctcf cDNA were obtained from GenScript in pUC19 vectors.

Techniques: Binding Assay, Mutagenesis

CTCF mutations alter gene expression, cellular reprogramming, and TF binding (A) Heatmap showing supervised clustering of the cell lines based on the expression levels of DEGs identified across the comparisons to WT. (B) Gene set enrichment analysis of DEGs in IAA condition and in H455R. The volcano plots below highlight the DEGs belonging to these enriched pathways. (C) Radar plots showing the averaged expression of developmental germ layer genes in WT and mutant mESCs cultured in LIF and no LIF conditions. (D) Heatmap showing predicted differentially bound TFs in WT, mutants and IAA. CTCF is highlighted with an asterisk (∗). (E) Volcano plots highlighting the differentially expressed target genes of CTCF and MBD2 in IAA and CTCF mutants. The metrics for enrichment of the target genes among the DEGs are reported on top on the volcanos (ORs and logistic p values). (F) Examples of altered CTCF binding and footprinting at the Rerg promoter (left) and altered MYC footprinting at the Brdt promoter (right). All data in this figure were generated on 2 replicates. See also <xref ref-type=Figures S17–S20 and Table S2. Differentially expressed genes (DEGs) identified using DE-seq. DEGs were defined as adjusted genes with p-value<0.05 and absolute log2 fold change > log2(1.5) compared to WT , Table S3. CTCF mutations altered cell differentiation , Table S4. CTCF mutations altered TF binding . " width="100%" height="100%">

Journal: Cell Genomics

Article Title: Binding domain mutations provide insight into CTCF’s relationship with chromatin and its contribution to gene regulation

doi: 10.1016/j.xgen.2025.100813

Figure Lengend Snippet: CTCF mutations alter gene expression, cellular reprogramming, and TF binding (A) Heatmap showing supervised clustering of the cell lines based on the expression levels of DEGs identified across the comparisons to WT. (B) Gene set enrichment analysis of DEGs in IAA condition and in H455R. The volcano plots below highlight the DEGs belonging to these enriched pathways. (C) Radar plots showing the averaged expression of developmental germ layer genes in WT and mutant mESCs cultured in LIF and no LIF conditions. (D) Heatmap showing predicted differentially bound TFs in WT, mutants and IAA. CTCF is highlighted with an asterisk (∗). (E) Volcano plots highlighting the differentially expressed target genes of CTCF and MBD2 in IAA and CTCF mutants. The metrics for enrichment of the target genes among the DEGs are reported on top on the volcanos (ORs and logistic p values). (F) Examples of altered CTCF binding and footprinting at the Rerg promoter (left) and altered MYC footprinting at the Brdt promoter (right). All data in this figure were generated on 2 replicates. See also Figures S17–S20 and Table S2. Differentially expressed genes (DEGs) identified using DE-seq. DEGs were defined as adjusted genes with p-value<0.05 and absolute log2 fold change > log2(1.5) compared to WT , Table S3. CTCF mutations altered cell differentiation , Table S4. CTCF mutations altered TF binding .

Article Snippet: Construction of vector for cloning transgenic, doxycycline-inducible expression of WT and mutant mouse Ctcf cDNA were obtained from GenScript in pUC19 vectors.

Techniques: Gene Expression, Binding Assay, Expressing, Mutagenesis, Cell Culture, Footprinting, Generated, Cell Differentiation

CTCF mutations alter chromatin interactivity (A) The top panels show the aggregated differential TAD analysis between mutants and WT. In the first panel, (a) indicates the intra-TAD interaction, (b) and (c) the inter-TAD interactions. The lower panels show the aggregated differential peak analysis. The data were generated by Hi-C on 2 replicates. (B) Correlation between the interaction counts and the FRAP residence times. (C) Correlation between the insulation score at CTCF peaks and the FRAP residence times. (D) Correlation between the loop extrusion length and the FRAP bound fractions. (E) Example of differential interactions between mutants and WT (right). The left matrix shows interactions in WT within a 10 Mb region (40 kb resolution) with the insulation score on the side. (F) Profiles show the averaged insulation score at WT-only, common, and mutant-only binding sites. (G) Profiles show the insulation score at CTCF binding sites stratified by CTCF signals. The bar graph shows the independent effect of CTCF signal on insulation score. (H) Profiles show the insulation score at CTCF binding sites stratified by ATAC signals. The bar graph shows the independent effect of ATAC signal on insulation score. For (F)–(H), p values reported in the profiles were calculated using Kruskal-Wallis tests. The fitted estimates for the bar graphs in (G) and (H) were obtained using a mixed multivariate model. The error bars correspond to the 95% CI. See also <xref ref-type=Figures S21–S24 . " width="100%" height="100%">

Journal: Cell Genomics

Article Title: Binding domain mutations provide insight into CTCF’s relationship with chromatin and its contribution to gene regulation

doi: 10.1016/j.xgen.2025.100813

Figure Lengend Snippet: CTCF mutations alter chromatin interactivity (A) The top panels show the aggregated differential TAD analysis between mutants and WT. In the first panel, (a) indicates the intra-TAD interaction, (b) and (c) the inter-TAD interactions. The lower panels show the aggregated differential peak analysis. The data were generated by Hi-C on 2 replicates. (B) Correlation between the interaction counts and the FRAP residence times. (C) Correlation between the insulation score at CTCF peaks and the FRAP residence times. (D) Correlation between the loop extrusion length and the FRAP bound fractions. (E) Example of differential interactions between mutants and WT (right). The left matrix shows interactions in WT within a 10 Mb region (40 kb resolution) with the insulation score on the side. (F) Profiles show the averaged insulation score at WT-only, common, and mutant-only binding sites. (G) Profiles show the insulation score at CTCF binding sites stratified by CTCF signals. The bar graph shows the independent effect of CTCF signal on insulation score. (H) Profiles show the insulation score at CTCF binding sites stratified by ATAC signals. The bar graph shows the independent effect of ATAC signal on insulation score. For (F)–(H), p values reported in the profiles were calculated using Kruskal-Wallis tests. The fitted estimates for the bar graphs in (G) and (H) were obtained using a mixed multivariate model. The error bars correspond to the 95% CI. See also Figures S21–S24 .

Article Snippet: Construction of vector for cloning transgenic, doxycycline-inducible expression of WT and mutant mouse Ctcf cDNA were obtained from GenScript in pUC19 vectors.

Techniques: Generated, Hi-C, Insulation, Mutagenesis, Binding Assay

Changes in gene expression are linked to changes in chromatin interactivity but to a lesser extent than changes in TF binding at gene promoters (A) Bar graphs showing the enrichment of over-expressed (top) or under-expressed (bottom) genes in gained (top) or lost (bottom) loops in IAA and mutants compared to WT. ORs and p values were calculated using logistic models. (B) Example of 2 loci (blue and red rectangles) with a direct effect of gain in CTCF binding and chromatin interactivity. The interaction matrices (left) show gain of both intra- and inter-TAD interactions in some mutants compared to WT. The left panels show the zoom-in tracks of these loci. Only significant differential chromatin loops are shown. Overexpressed genes are highlighted in red. (C) Bar graph showing the percentage of DEGs resulting from direct or indirect effect of CTCF binding distinguishing loop dependent and independent effect.

Journal: Cell Genomics

Article Title: Binding domain mutations provide insight into CTCF’s relationship with chromatin and its contribution to gene regulation

doi: 10.1016/j.xgen.2025.100813

Figure Lengend Snippet: Changes in gene expression are linked to changes in chromatin interactivity but to a lesser extent than changes in TF binding at gene promoters (A) Bar graphs showing the enrichment of over-expressed (top) or under-expressed (bottom) genes in gained (top) or lost (bottom) loops in IAA and mutants compared to WT. ORs and p values were calculated using logistic models. (B) Example of 2 loci (blue and red rectangles) with a direct effect of gain in CTCF binding and chromatin interactivity. The interaction matrices (left) show gain of both intra- and inter-TAD interactions in some mutants compared to WT. The left panels show the zoom-in tracks of these loci. Only significant differential chromatin loops are shown. Overexpressed genes are highlighted in red. (C) Bar graph showing the percentage of DEGs resulting from direct or indirect effect of CTCF binding distinguishing loop dependent and independent effect.

Article Snippet: Construction of vector for cloning transgenic, doxycycline-inducible expression of WT and mutant mouse Ctcf cDNA were obtained from GenScript in pUC19 vectors.

Techniques: Gene Expression, Binding Assay